Although GLP-1 drugs have existed for at least a decade, they did not truly hit the headlines until this year
[6] There is no official evidence that tirzepatide causes physical dependence or withdrawal symptoms in the traditional sense, but the underlying metabolic conditions will reassert themselves without ongoing pharmacological support
Patients with pre-existing diabetic retinopathy should be monitored when glycaemic control improves rapidly, as this can temporarily worsen retinopathy regardless of the treatment used
Many patients are discovering that Wegovy in Mexico offers significant cost savings compared to prices in the United States
At Frisco Quick Care, patients seeking medical weight-loss guidance can receive education on how Wegovy works, who may be an appropriate candidate, and how it fits into a broader health plan that includes nutrition and lifestyle considerations
So more than one in 10 American adults is currently using a GLP-1 drug for weight loss, and more than one in seven have used it at some point in the past, the Gallup Index revealed